Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

Molecular and Cellular Biology

Volumn 15, Issue 10, 1995, Pages 5789-5799

  Alroy, Iris ^a   Towers, Terri L ^a   Freedman, Leonard P ^a  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; HORMONE RECEPTOR; INTERLEUKIN 2; VITAMIN RECEPTOR;

ARTICLE; COMPLEX FORMATION; DNA BINDING; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0029149894     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.15.10.5789     Document Type: Article

References (88)

1. 3. Proc. Natl. Acad. Sci. USA 78:4990-4994.
2. Akerblom, I. E., E. P. Slater, M. Beato, J. D. Baxter, and P. L. Mellon. 1988. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 241:350-353.
3. 2a. Alroy, I. 1995. Ph.D. thesis. Cornell University, Ithaca, N.Y.
4. Alroy, I., and L. P. Freedman. 1992. DNA binding analysis of glucocorticoid receptor specificity mutants. Nucleic Acids Res. 20:1045-1052.
5. 3 induces the maturation of the human monocyte cell line U937, and in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J. Clin. Invest. 73:731-740.
6. Baker, A. R., D. P. McDonnell, M. Hughes, T. M. Crisp, D. J. Mangelsdorf, M. R. Haussler, J. W. Pike, J. Shine, and B. W. O'Malley. 1988. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 85:3249-3298.
7. 3. Proc. Natl. Acad. Sci. USA 80:5907-5911.
8. Bettens, F., F. Kristensen, C. Walker, U. Schwulera, G. D. Bonnard, and A. L. Weck. 1984. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocytes. J. Immunol. 132:261-267.
9. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57:1308-1310.
10. 3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol. 98:311-322.
11. 3 inhibits antigen-induced T cell activation. J. Immunol. 133:1748-1754.
12. Boise, L. H., B. Petryniak, X. Mao, C. H. June, C.-Y. Wang, T. Lindsten, R. Bravo, K. Kovary, J. M. Leiden, and C. B. Thompson. 1993. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13:1911-1919.
13. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol. Cell. Biol. 14:3329-3338.
14. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045-1083.
15. Diamond, M. I., J. N. Miner, S. K. Yoshinaga, and K. R. Yamamoto. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
16. Drouin, J., Y. L. Sun, M. Chamberland, Y. Gauthier, A. D. Lean, M. Nemer, and T. J. Schmidt. 1993. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12:145-156.
17. Durand, D. B., M. R. Bush, J. G. Morgan, A. Weiss, and G. R. Crabtree. 1987. A 275 basepair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165:395-407.
18. Durand, D. B., J.-P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
19. Emmel, E. A., C. L. Verweij, D. B. Durand, K. M. Higgins, E. Lacy, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617-1619.
20. Felli, M. P., A. Vacca, D. Meco, I. Scepanti, A. R. Farina, M. Maroder, S. Martinotti, E. Petrangeli, L. Frati, and A. Gulino. 1991. Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol. Cell. Biol. 11:4771-4778.
21. Flanangan, W. M., B. Corthesy, R. J. Bram, and G. R. Crabtree. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin. Nature (London) 352:803-807.
22. 3 receptor in the absence of the retinoid X receptor. Mol. Endocrinol. 8:265-273.
23. Freedman, L. P., and B. Lemon. Unpublished data.
24. 3 receptor zinc finger region. Mol. Endocrinol. 5:1815-1826.
25. Fujita, T., H. Shibuya, T. Ohashi, K. Yamanishi, and T. Taniguchi. 1986. Regulation of human interleukin-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes. Cell 46:401-407.
26. Gillis, S., G. R. Crabtree, and K. A. Smith. 1979. Glucocorticoid-induced inhibition of T cell growth factor production. J. Immunol. 123:1624-1631.
27. Goodbourn, S. 1994. Transcriptional regulation in activated T cells. Curr. Biol. 4:930-932.
28. Heck, S., M. Kullmann, A. Gast, H. Ponta, H. J. Rahmsdorf, P. Herrlich, and A. C. B. Cato. 1994. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13:4087-4095.
29. Hentsch, B., A. Mouzaki, I. Pfeuier, D. Rungger, and E. Serfling. 1992. The weak, fine-tuned binding of ubiquitous transcription factors to the IL-2 enhancer contributes to its T cell-restricted activity. Nucleic Acids Res. 20:2657-2665.
30. Hoey, T., Y.-L. Sun, K. Williamson, and X. Xu. 1995. Isolation of two new members of the NF-AT gene family and functional characterization of NF-AT proteins. Immunity 2:461-472.
31. Holbrook, N. J., K. A. Smith, J. Furnace, C. M. Comeau, R. L. Wiskocil, and G. R. Crabtree. 1984. T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc. Natl. Acad. Sci. USA 81:1643-1638.
32. Hudson, L. G., J. B. Santon, C. K. Glass, and G. N. Gill. 1990. Ligand-activated thyroid hormone and retinoid acid receptors inhibit growth factor receptor promoter expression. Cell 62:1165-1175.
33. Jain, J., E. Burgeon, T. M. Badalian, P. G. Hogan, and A. Rao. 1995. A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J. Biol. Chem. 270:4138-4195.
34. Jain, J., Z. Miner, and A. Rao. 1993. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151:837-848.
35. Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerpolla, J. N. Lambert, G. L. Verdine, T. Curran, and A. Rao. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature (London) 365:352-355.
36. Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cell contains Fos and Jun. Nature (London) 356:801-804.
37. Jonat, C., H. J. Rahmsdorf, K.-K. Park, A. C. B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
38. 3-deficient diet. Immunology 73:466-471.
39. Kerppola, T. K., D. Luk, and T. Curran. 1993. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13:3782-3791.
40. 3 signalling. Nature (London) 355:446-449.
41. Konig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241-2246.
42. Kutoh, E., P.-E. Stromstedt, and L. Poellinger. 1992. Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. Mol. Cell. Biol. 12:4960-4969.
43. Leftsin, J. A., J. R. Thomas, and K. R. Yamamoto. 1994. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 8:2842-2856.
44. 3 suppresses human T helper/ inducer lymphocyte activity in vitro. J. Immunol. 134:3032-3039.
45. 3 suppresses proliferation and immunoglobulin production by normal human blood mononuclear cells. J. Clin. Invest. 74:1451-1462.
46. 3 receptor and other nonreceptor transcription factors. Mol. Endocrinol. 8:1593-1604.
47. Lowe, K. E., A. C. Maiyar, and A. W. Norman. 1992. Vitamin D-mediated gene expression. Crit. Rev. Eukaryotic Gene Expression 2:65-109.
48. Luisi, B. F., W. X. Xu, Z. Otwinowski, L. P. Freedman, K. R. Yamamoto, and P. B. Sigler. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (London) 352:497-505.
49. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13:5907-5917.
50. Mangelsdorf, D. J., J. W. Pike, and M. R. Haussler. 1984. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J. Cell. Biol. 98:391-398.
51. Masuda, E. S., Y. Naito, H. Tokumitsu, D. Campbell, F. Saito, C. Hannum, K.-I. Ami, and N. Arai. 1995. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed primarily in the thymus. Mol. Cell. Biol. 15:2697-2706.
52. Mattila, P. S., K. S. Ullman, S. Hering, E. A. Emmel, M. McCutcheon, G. R. Crabtree, and L. A. Herzenberg. 1990. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9:4425-4433.
53. McCaffrey, P. G., A. E. Goldfeld, and A. Rao. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-α gene transcription. J. Biol. Chem. 269:30445-30450.
54. McCaffrey, P. G., J. Jain, C. Jamieson, R. Sen, and A. Rao. 1992. A T cell nuclear factor resembling NFAT binds to an NF-κB site and to the conserved lymphokine promoter sequence "cytokine-1." J. Biol. Chem. 267: 1864-1871.
55. McCaffrey, P. G., C. Luo, T. K. Kerppola, J. Jain, T. M. Badalian, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao, and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262:750-754.
56. McCaffrey, P. G., B. A. Perrino, T. R. Soderling, and A. Rao. 1993. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J. Biol. Chem. 268:3747-3752.
57. Miner, J. N., and K. R. Yamamoto. 1991. Regulatory crosstalk at composite response elements. Trends Biochem. Sci. 16:423-426.
58. Miner, J. N., and K. R. Yamamoto. 1992. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev. 6:2491-2501.
59. 3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation. Cancer Res. 46:5827-5831.
60. Nolan, G. P. 1994. NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influence. Cell 77:795-798.
61. Northrop, J. P., S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon, and G. R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature (London) 369:497-502.
62. Northrop, J. P., K. S. Ullman, and G. R. Crabtree. 1993. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cell (NF-AT) complex. J. Biol. Chem. 268:2917-2923.
63. Pfahl, M. 1993. Nuclear receptor/AP-1 interaction. Endocrine Res. 14:651-658.
64. 3 receptors: structure and function in transcription. Annu. Rev. Nutr. 11:189-216.
65. Ponta, H., A. C. B. Cato, and P. Herrlich. 1992. Interference of pathway specific transcription factors. Biochim. Biophys. Acta 1129:255-261.
66. 64a. Rao, A. Personal communication.
67. Rao, A. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15:274-281.
68. Rigby, W. F. C. 1988. The immunobiology of vitamin D. Immunol. Today 8:54-58.
69. 3. J. Clin. Invest. 79:1659-1664.
70. 3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J. Immunol. 135:2279-2285.
71. 3 (calcitriol). J. Clin. Invest. 74:1451-1455.
72. Sakai, D. D., S. Helms, J. Carldtedt-Duke, J.-A. Gustafsson, F. M. Rottman, and K. R. Yamamoto. 1988. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2:1144-1154.
73. 70a. Salbert, G., A. Fanjul, F. J. Piedraflra, X. P. Lu, S-J. Kim, P. Tran, and M. Pfahl. 1993. Retinoid acid receptors and retinoid X receptor-α down regulate the transforming growth factor-β1 promoter activity by antagonizing AP-1 activity. Mol. Endocrinol. 7:1347-1356.
74. Schena, M., L. P. Freedman, and K. R. Yamamoto. 1989. Mutations in the glucocorticoid zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev. 3:1590-1601.
75. Schorlemmer, J., A. V. Puijenbroek, M. van den Eijnden, L. Jonk, C. Pals, and W. Kruijer. 1994. Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol. Cell. Biol. 14:1122-1136.
76. Schule, R., and R. M. Evans. 1991. Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet. 7:377-381.
77. Schule, R., P. Rangarajan, S. Kliewer, L. J. Ransone, J. Bolado, N. Yang, J. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
78. Siebenlist, U., D. B. Durand, P. Bressler, N. J. Holbrook, C. A. Norris, M. Kamoun, J. A. Kant, and G. R. Crabtree. 1986. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol. Cell. Biol. 6:3042-3049.
79. Sone, T., S. Kerner, and J. W. Pike. 1991. Vitamin D receptor interaction with specific DNA. J. Biol. Chem. 266:23296-23305.
80. 3 in normal human peripheral blood monocytes. J. Clin. Invest. 79:1700-1705.
81. 3 receptor: mechanism of dimer binding to an asymmetric repeat element. Proc. Natl. Acad. Sci. USA 90:6310-6314.
82. 3: a novel immunoregulatory hormone. Science 224:1438-1441.
83. Vacca, A., M. P. Felli, A. R. Farina, S. Martinotti, M. Maroder, I. Screpanti, D. Meco, E. Petrangeli, L. Frati, and A. Gulino. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175:637-646.
84. Vacca, A., S. Martinotti, I. Screpanti, M. Maroder, M. P. Felli, A. R. Farina, A. Gismondi, A. Santoni, L. Frati, and A. Gulino. 1990. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5′ flanking sequences. J. Biol. Chem. 265:8075-8080.
85. Wahli, W., and E. Martinez. 1991. Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J. 5:2243-2249.
86. Yang-Yen, H.-F., J.-C. Chambard, Y.-L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
87. Zhang, X.-K., J.-M. Dong, and J.-F. Chiu. 1991. Regulation of α-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. J. Biol. Chem. 266:8248-8254.
88. Zhang, X.-K., K. N. Wills, M. Husmann, T. Hermann, and M. Pfahl. 1991. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol. Cell. Biol. 11:6016-6025.